Evaluation of T-cell responses to peptides and lipopeptides with MHC class I binding motifs derived from the amino acid sequence of the 19-kDa lipoprotein of mycobacterium tuberculosis

Molecular Immunology

Volumn 37, Issue 8, 2000, Pages 413-422

  Fonseca, Dora P A J ^a,b   Joosten, Dianne ^a   Snippe, Harm ^a   Verheul, André F M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

19 kDa protein; CTL; MHC class I; Tuberculosis

Indexed keywords

EPITOPE; FREUND ADJUVANT; LIPOPEPTIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MYCOBACTERIUM ANTIGEN; PEPTIDE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; HELPER CELL; IMMUNE RESPONSE; LYMPHOMA CELL LINE; MOLECULAR STABILITY; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROCESSING; PROTEIN SYNTHESIS; RECEPTOR UPREGULATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, BACTERIAL; CHROMIUM; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS I; INTERFERON TYPE II; INTERLEUKIN-4; LIPOPROTEINS; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM TUBERCULOSIS; PEPTIDE FRAGMENTS; PROTEIN BINDING; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED; UP-REGULATION;

ACTINOBACTERIA (CLASS); ANIMALIA; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; UNCULTURED ACTINOMYCETE;

EID: 0033679243     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(00)00066-3     Document Type: Article

References (59)

1. In vitro selection of lymphocytic choriomeningitis virus escape mutants by cytotoxic T-lymphocytes
2. Nucleotide sequence of the 19kDa antigen gene from Mycobacterium tuberculosis
3. The mapping of an antibody-binding region on the 19 kilodalton antigen
4. TAP1-in-dependent loading of class I molecules by exogenous viral proteins
5. Induction of CD8 cytotoxic T lymphocyte response by cross-priming requires cognate CD4 help
6. Peptide-induced conformational changes in class I heavy chains alter major histocompatibility complex recognition
7. In vivo and in vitro characterization of murine T cell clones reactive to Mycobacterium tuberculosis
8. + T cells
9. Major histocompatibility complex conformational epitopes are peptide specific
10. Disseminated tuberculosis in interferon-γ gene disrupted mice
11. Identification of new cytotoxic T-cell epitopes on the 38 kD lipoglycoprotein of Mycobacterium tuberculosis by using lipopeptide
12. + T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection
13. In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine
14. Structure of peptides associated with MHC class I molecules
15. + T-cell priming against the identified peptides after DNA-vaccination of mice
16. Analysis of human T-cell epitopes in the 19,000 MW antigen of Mycobacterium tuberculosis: Influence of HLA-DR
17. Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells
18. Efficient MHC class I-peptide binding is required but does not ensure MHC class I-restricted immunogenicity
19. An essential role for interferon-γ in resistence to Mycobacterium tuberculosis infection
20. Murine T cell-stimulatory peptides from the 19-kDa antigen of Mycobacterium tuberculosis. Epitope-restricted homology with the 28-kDa protein of Mycobacterium leprae
21. Genetically permissive recognition of adjacent epitopes from the 19-kDa antigen of Mycobacterium tuberculosis by human and murine T cells
22. T cells responses to a mixture of Mycobacterium tuberculosis peptides with complementary HLA-DR binding profiles
23. The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses
24. Mycobacterial-induced cytoxic T cells as well as nonspecific killer cells derived from healthy individuals and leprosy Patients
25. Tuberculosis, the role of the immune system
26. Helper activity is required for the in vivo generation of cytotoxic T lymphocyte
27. BCG vaccination, can it contribute to tuberculosis control?
28. Prediction and identification of an HLA-DR-restrict T cell determinant in the 19kDa protein of Mycobacterium tuberculosis
29. CTL escape viral variants: I. Generation anti molecular characterization
30. In vivo CTL induction with point-substituted ovalbumin peptides: Immunogenicity correlates with peptide-induced MHC class I stability
31. Empty MHC class I molecules come out in the cold
32. Immunization of mice with lipopeptides bypasses the prerequisite for adjuvant
33. CTL response to Mycobacterium tuberculosis: Identification of an immunogenic epitope in the 19-kDa lipoprotein
34. T cell responses of normal individuals towards recombinant protein antigens Mycobacterium tuberculosis
35. Human T cell clones recognize two abundant Mycobacterium tuberculosis antigens expressed in E. Coll
36. Role of cytotoxic cells in the protective immunity against and immunopathology of intracellular infections
37. Induction of cytotoxic T-cell activity by the protective antigen of Schistosoma mansoni Sm28GST or its derived C-terminal lipopeptide
38. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells
39. Specificity of proliferative response of human CD8 clones to mycobacterial antigens
40. The effect of lipoylation on CD4 T-cell recognition of the 19,000 MW Mycobacterium tuberculosis antigen
41. Quantitation of peptide anchor residue contributions to class I major histocompatibility complex molecule binding
42. Efficiency of peptides and lipopeptides for in vivo priming of virus-specific cytotoxic T cells
43. Hepatitis B virus small surface antigen particles are processed in a novel endosomal pathway for major histocompatibility complex class I-restricted epitope presentation
44. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes
45. Roles of proteasomes, transporter for antigen presentation (TAP), and b2-microglobulin in the processing of bacterial or particulate antigens via an alternate class I MHC processing pathway
46. Cytotoxic T cell responses to intracellular pathogens
47. Th1/Th2 profiles in tuberculosis based on proliferation and cytokine response of blood lymphocytes to mycobacterial antigens
48. Vaccination against tuberculosis by DNA injection
49. + T cells requires the production of Interferon-γ
50. + T cells in vitro
51. Monopalmitic acid-peptide conjugates induce cytotoxic T cell responses against malarial epitopes: Importance of spacer amino acids
52. + CTL recognizing mycobacterial peptides
53. + T cells in healthy contacts of tuberculosis
54. Lipoprotein antigens of Mycobacterium tuberculosis
55. In vivo priming of cytotoxic T lymphocyte responses in relation to m vitro up-regulation of major histocompatibility complex class I molecules by short synthetic peptides
56. In vivo primary induction of virus-specific CTL by immunization with 9-mer synthetic peptides
57. Functions and specificity of T cells following nucleic acid vaccination of mice against Mycobacterium tuberculosis infection
58. + T cells from subunit-vaccinated and infected H-2b mice recognizing the 38 kDa antigen of Mycobacterium tuberculosis